IGF1R and neoplasm: Mechanistically, PRKCSH interrupts TNFSF-mediated apoptotic signaling by promoting IGF1R activation in tumor cells without affecting the expression of TNFSF receptors, resulting in the inhibition of tumor cell death (Supplementary Fig. 11).